President update 28th July 2020 Shielding advice –  What will change from 1 August

President update 28th July 2020 Shielding advice – What will change from 1 August

The current BSPGHAN advice on shielding will change on  August 1st in line with Government advice.

From 1 August, the government will pause shielding unless the transmission of COVID-19 in the community starts to rise significantly.

See GOV.UK: guidance on shielding and protecting people who are clinically extremely vulnerable from coronavirus.    **

This guidance will be updated on 1 August.

See specific advice for our patients’ families

**Clinically extremely vulnerable children and young people (0 to 18)

Specialists in paediatric medicine have reviewed the evidence on the level of risk posed to children and young people from COVID-19. The latest evidence indicates that the risk of serious illness for most children and young people is low.

All children and young people currently identified as Clinically Extremely Vulnerable, and advised to shield, should continue to do so until 31 July, when the government will pause shielding for everyone.

All decisions on whether children and young people should be removed from the shielded patient list (and therefore will not be advised to shield again in future if transmission starts to increase significantly) should be based on a consultation with a paediatric specialist or GP who will be best placed to determine the most appropriate care. advises that a paediatric specialist or GP will be in touch over the summer to have these discussions.

Returning to school

  • children who are clinically extremely vulnerable can go back to school (when the rest of their class goes back)

See guidance on supporting children and young people’s mental health and wellbeing.

This advice is of a general nature and should be treated as a guide.

This does not replace any local public health measures put in place to protect the local population. If there is an outbreak of COVID-19 within your area, please follow any guidance set out locally or any specific law which applies to the area you live in  .If local restrictions are in place in your area, please visit local lockdowns guidance

Best wishes
BSPGHAN President July 28th 


President Update 13th July 2020

President Update 13th July 2020

BSPGHAN Educational events 2020 and Annual Meeting 2021 

Please Save The Dates in your diary

  1. BSPGHAN Annual Meeting and AGM January 27, 2021- January 28, 2021
  2. BSPGHAN Masterclass  “Intestinal Failure – Past, Present and Future”? August 12th, 2020 14.00 -15.00  
  3. BSPGHAN Trainees meeting August 19th 2020 13.00-16.00

The pandemic has given us  unique challenges  in delivering and hosting educational events, especially our  upcoming annual BSPGHAN meeting.

Our trainees have led the way and pulled together highly successful Zoom educational initiatives.

Following discussion at Council, Dr Ronald Bremner, my co-host,  and I have agreed to arrange a virtual annual meeting and AGM in 2021,  harnessing the recent success of weekly trainees’ online events.

What’s new

Virtual annual meeting and AGM January 2021

We plan to offer interactive “live” panel discussions and debates to  continue our professional and friendly interactions on January 28th, 2021.

For abstract submission and management, we will use the online system that worked well last year and offer  poster submission with poster walks using uploaded video presentations alongside.

Following demand, we plan to offer to stream parallel sessions for the Associates, Trainees and PeGHAN colleagues on the first day January 27th 2021. We are willing to secure a venue to host a small face-to-face meeting alongside the online annual meeting nearer the time if this is in demand. We hope that this hybrid meeting will offer the best of both worlds. It may become the template for meetings in future, hopefully with a large proportion of the meeting being face-to-face in future. Council have agreed that we run a meeting in Birmingham in 2021.

Please book your study leave now.

Twitter     –    The trainees, led by Joe Chan and supported by Mark Beattie  plan to use our BSPGHAN Twitter account take on a larger role for the virtual meeting.

Uses will include publicising upcoming talks, facilitating online discussions and post-talk questions for the speakers. 

The first BSPGHAN Masterclass on 12th August 2020

You are invited to join the first BSPGHAN Masterclass on August 12th, 2020 14.00-15.00.  Dr Sue Protheroe will deliver a talk on ‘Intestinal Failure; Past Present and Future’. Time and registration details will be circulated shortly  “BSPGHAN Masterclasses” will invite a wider audience (to include international trainees, non-GI health professionals, non-BSPGHAN members) with the intention of sharing GI learning to a wider audience, and extending the society’s reach and influence.

BSPGHAN Trainee’s meeting on 19 August 2020 ;

A trainee members’ meeting has been organised by Dr Neil McConnell, chair of the Trainee Group.  The programme is being finalised and will be uploaded shortly.  Talks will cover why to train in gastroenterology and hepatology; insight into the START Exams and Consultant Interview Tips.  This meeting is open to Trainees and those who may be interested in a career in Gastroenterology and Hepatology.

Returning to Hospital Schools

The Department for Education has published a suite of guidance relating to school opening in September.  It is the intention of the department that all pupils, in all year groups, will return to school full-time from the beginning of the autumn term.  From 1 June, DfE asked schools to begin welcoming back more pupils in specific year groups.  Hospital schools on hospital sites were asked to work towards a phased return of more children and young people without a focus on specific year groups and informed by risk assessments.   Since then, the prevalence of coronavirus (COVID-19) has decreased,  the NHS Test and Trace system is up and running, and there are clear measures that need to be in place to create safer environments within schools.

 Returning to school is vital for children’s education and for their wellbeing, and we therefore need to ensure all pupils can return to school sooner rather than later.  This includes pupils receiving hospital education on hospital sites.As you will see from the guidance (, we are asking hospitals to work with the relevant Infection Prevention and Control team and NHS Trust to ensure that all pupils educated on hospital sites are able to return to education in September where it is safe and feasible to do so and in line with hospital IPC measures.  We  expect headteachers and NHS trusts to work together over the summer holidays and beyond, to enable the return of all pupils at the start of the autumn term. We would be very grateful if you could share the guidance with the relevant members of your staff teams to ensure key messages are widely distributed and to enable planning for September to commence

Best wishes,
Sue Protheroe
BSPGHAN President

Presidents Update June 28th 2020:  1. Pause of BSPGHAN/RCPCH  Quality Standards Audit; 2;  Shielding Update 3.  Innovations. 4. ACCEA update

Presidents Update June 28th 2020: 1. Pause of BSPGHAN/RCPCH Quality Standards Audit; 2; Shielding Update 3. Innovations. 4. ACCEA update

Dear Members

  1. Pause of the National Audit of Quality Standards for Paediatric Gastroenterology, Hepatology and Nutrition (‘the PGHAN Audit’).

The RCPCH/BSPGHAN PGHAN Audit Project Team have put the audit on hold during the COVID-19 pandemic and will reinvigorate the audit in August. The pause has given us an opportunity to discuss consider potential changes to the dataset that might be required due to the effects of COVID-19 on the healthcare system and PGHAN services in particular. 

I am grateful for all of your input and support with the PGHAN Audit to date.  The dataset had been agreed and built into a data platform which was ready to pilot in May/June. The PGHAN Audit clinical lead had registered in around 45% of Health Boards and Trusts across the UK by the end of April. 

Please can I ask you to contact your Medical Director if you haven’t recruited a PGHAN Audit clinical lead.

The pause in the audit has offered us chance to reflect on its purpose in the context of BSPGHAN’s strategic intentions-

  1. To continue to examine PGHAN professional networks and see how BSPGHAN can support research, education and training,
  2. To allow us to consider the impact and value on PGHAN health care provision that the BSPGHAN Clinical Standards provide, 
  3. To reflect critically on BSPGHAN’s function, to promote national best practice and outcomes of our patients especially moving forward from paused activity, 
  4. To harness opportunities to support service resetting and recovery post COVID-19, and how this may be done at a national level,
  5. To harness opportunities to sustain any positive changes in the way we work, capturing innovations that have been rapidly developed during the pandemic  (Please still feedback to me on innovations. See below **).

Additionally, it is timely to reflect on further intentions-

  1. To accelerate BSPGHAN’s national education strategy to develop virtual learning opportunities for trainees and members,
  2. To use our new website to share education / clinical updates; to measure the impact of the content of our new site;
  3. To build on the closer links that have arisen during the pandemic when writing joint rapid updates for example;  for BSPGHAN to work more closely with key stakeholders such as the BSG, Royal College and charitable partners
  4. To support the productivity of  BSPGHAN “task and finish” projects– using virtual get togethers. I hope that remote meetings will encourage participation from more members from devolved nations and foster rapid outputs from council and working groups.

2. Shielding Update

I know most  will have seen the latest shielding letter from the Chief Medical Officer & NHS Medical Director  AVAILABLE HERE  which provides New clinical evidence on children  

Recent experience and knowledge of the impact COVID-19 infection has on children and young people with comorbidities suggests not all those on the Shielded Patient List need to be shielding. RCPCH recently published  updated guidance  which paediatric patient groups they think should be advised to shield. They have identified three groups:

  • children and young people who are cared for just in primary care are very unlikely to need to continue to shield;
  • a small group of children who are clinically extremely vulnerable due to their pre-existing condition will need to continue to shield; and
  • a further larger group of children exists who due to their underlying condition may need to shield and the decision to continue to shield would normally result from a discussion between the clinician, the child and their family.

RCPCH expect that all patients who need to continue to shield will be seen in a specialist centre before September 2020 (but not all those with specialist appointments will need to shield).  Decisions on shielding will generally be led by a specialist, balancing the clinical and social impact of shielding. Patients should only be removed from the Shielded Patient List by their GP or specialist following consultation with the child and their family, and other clinicians where appropriate.

Further guidance on having conversations with children and families can be found on the   RCPCH website The Government works closely with the RCPCH and welcomes their valuable scientific input. We recommend that clinicians follow up with children (and their parents) on the Shielded Patient List to discuss what RCPCH guidance means for them.  

Risk stratification (adults) A team academics have been working with clinicians to develop a predictive risk model that reflects a wider range of factors such as demographics alongside long-term health conditions, to better understand cumulative risk of serious illness for individuals if they catch COVID-19.  The COVID19 risk stratification model will be set out in the BMJ soon . It will only be for people aged 18 years as fortunately there’s a paucity of data for modelling in children and young people  —  see the publication of the research protocol

3. Feedback from members on Service Innovations **

I mentioned a few weeks back,  I am keen to capture service changes relevant to our patients.

This is a polite nudge to ask those of you who haven’t got back to me,  for your thoughts,  so that I can make sure they’re captured.  

See survey via this link  or see the questions below

The survey asks the following four questions:  

  1. What beneficial innovations/changes have occurred in your specialty and within patient pathways?  
  2. Please describe the impact of these innovations/ changes (e.g. population health outcome, patient outcome, safety, wider system, efficiency, productivity). How did you measure the benefit?  
  3. What is needed to sustain the change?  
  4. What, if anything, hasn’t worked so well. 

Thank you for getting back to me by 4pm on 30th June.  If you can’t make this deadline, please still feedback as your input will be useful to harness and share improvements in patient pathways.

 4. ACCEA secretariat update  

Ministers agreed the suspension of the 2020 national Clinical Excellence Awards round

Subject to Ministerial agreement, there will be an extended National awards 2021 competition, with a lengthened timetable from November 2020 until the end of January 2021. 

Please stay well and as always, I welcome your involvement and your feedback.

Best wishes
Sue  Protheroe
BSPGHAN  President
28th  June 2020

President Update 13th July 2020

President Update 14th June 2020

Dear members

COVID-19 has sadly shown that colleagues and patients from BAME communities have been disproportionately affected by COVID-19. Acknowledging and actively mitigating health inequalities is rightly high on our agenda. Recent events have additionally brought into sharp focus the need to tackle discrimination of any kind.  Many young people have led the way and seized the opportunity to highlight  these issues peacefully. Thinking of the  young people we look after, an opinion piece in The Lancet Child & Adolescent Health

has highlighted the damaging long term consequences of lack of face to face contact among young people and their peers.

We are now actively offering personalised discussions with families and young people to support continued shielding or easing of restrictions.  Not all those children and young people who are currently advised to shield need to continue to do so and can  return to school as it reopens where the benefits of school – in terms of access to therapies and developmental support – far outweigh the risk of infection.

This week, we will all wear face masks more widely and continue social distancing to keep our patients safe. The impact of the 2m social distancing rule in hospital impacts on our  ability to reset, restore and recover health services. In England, today the Government announced that it is undertaking a review of 2m rule regarding economic recovery and we await their deliberation. 

1. Shielding update for children and young people

On June 10th, the RCPCH released advice this advice on shielding guidance for children. Its aim is to support clinicians in their discussions with patients and their families/carers about the risks and benefits associated with shielding.   It specifically considers children with paediatric gastroenterology, hepatology and nutritional problems using the available evidence  More information is available from  British Society for Paediatric Gastroenterology, Hepatology and Nutrition.

The update seeks to support the trusted relationship between patients and their doctors.

RCPCH have offered advice regarding returning to school

In England, the NHS sent  a letter to NHS trusts and primary care on 4 June which outlines changes and the process for maintaining list of shielded patients (additions and removals) – see here:

1. Shielding update for children and young people

On June 10th, the RCPCH released advice this advice on shielding guidance for children. It’s aim is to support clinicians in their discussions with patients and their families/carers about the risks and benefits associated with shielding.   It specifically considers children with paediatric gastroenterology, hepatology and nutritional problems using the available evidence  More information is available from  British Society for Paediatric Gastroenterology, Hepatology and Nutrition.

The update seeks to support the trusted relationship between patients and their doctors.

RCPCH have offered advice regarding returning to school

In England, the NHS sent  a letter to NHS trusts and primary care on 4 June which outlines changes and the process for maintaining list of shielded patients (additions and removals) – see here:

Further advice is expected to be released this week from June 15th.

.2.  Updated shielding guidance for children with chronic liver disease and those on and those on immunosuppression (autoimmune liver disease and liver transplantation) June 11th

In view of evidence and increasing knowledge in the COVID-19 pandemic, the 3 paediatric Liver Centres updated the advice to children and families with chronic liver disease. This advice is generated following communication with colleagues from other societies (BTS, BLT, BSG, BASL)  and referencing to documents released by PHE, GOV, ERN-Rare Liver, RCPCH and NHSE.

  1. Exit strategy from the Coronavirus (Covid 19) lockdown and ‘enhanced social distancing’ (shielding) for children and young people receiving home parenteral nutrition (HPN); a decision making framework from the BSPGHAN Nutrition and Intestinal Failure working group 

Key points

  • children and young people receiving HPN were advised to ‘shield’ when lockdown commenced in March 2020
  • it is now apparent that gastrointestinal manifestations of Covid19 in children are mild and self limiting
  • we have not identified any reports of severe complications of covid19 in short bowel syndrome (SBS), intestinal failure (IF) or HPN from Covid19,  in the adult and paediatric medical literature
  • mental health of children required to take quarantine measures is well described with anxiety, distress and increased risk of major mental health disorders
  • all HPN children should no longer be considered ‘extremely vulnerable’ since negative social and developmental effects would appear to outweigh protection
  • patients and families should have a balanced conversation about returning to school. They may wish to take a tailored approach, such as following in two weeks behind their peers to assure that initial logistics of social distancing are being followed
  • If a child has coexisting disease, e.g. cardio-respiratory, neurodisability, immunodeficiency, inflammatory bowel disease (IBD) or is on certain immunosuppressive treatment that would not in itself be severe enough to warrant shielding, clinicians may wish, in conjunction with other speciality teams and families consider that the patient should continue shielding from cumulative multi-organ risk.
  1. The BSPGHAN motility working group has produced guidance on

Restarting neurogastroenterology and motility investigations in paediatrics. BSPGHAN Motility Working Group guidance (June 2020).

This describes restoration of neurogastroenterology for the common GI functional testing based of the best available evidence

During the height of Sars-CoV-2 transmission there were almost complete halt to gastrointestinal motility investigations as they are considered non urgent aerosol generating procedures (AGP). With the infection rate recessing in the UK, most NHS Trusts are slowly increasing capacity for elective work. Particular attention is drawn to AGP to minimise the infection risk to children and healthcare professionals.

The Motility Working Group aim is to provide guidance for clinicians on the safe restoration of selected gastrointestinal motility investigations; this guidance is based on the current evidence but this is a rapidly evolving subject and the guidance many change over time. The working group will endeavour to update this document if new information become available

  1. ESPGHAN Advice Guide – Treatment of Chronic Hepatitis C Infection in children

  1. BSG advice

 In guidance on restarting endoscopy services the BSG has suggested treating patients (< 55 years) with suspected coeliac disease and a tTG >x10ULN without biopsy.

Here is the protocol further detailing this advice, which is specific to the COVID-19 environment and has been issued as interim guidance pending the publication of the new BSG Coeliac Guideline expected to be published in 2021.

Management of acute severe ulcerative colitis (ASUC) during the novel coronavirus 2019 (COVID-19) pandemic presents significant dilemmas. The BSG panel includes members of BSPGHAN and aimed to provide COVID-19-specific guidance using current British Society of Gastroenterology (BSG) guidelines as a reference point.

With very best wishes to you all. 

BSPGHAN  President, e-mail
June 14th 2020


President Update 7th June 2020

President Update 7th June 2020

Dear members

This week there is has been much to watch. We are uncertain what releasing of lockdown means in terms of keeping our patients and ourselves safe; what antibody testing of NHS staff may mean, if contact tracing, and wearing of surgical masks in public, and quarantine for travellers,  may contain a second wave of Covid-19.  We are watching out for the new paediatric multi system inflammatory syndrome, vaccine development , and the scramble for Covid-19 trial outcomes. What does seem certain is that harnessing new ways of working, planning the recovery of services and maintaining social distancing will be important to maintain for many months as we move out of lockdown and start to resume paused activity.
Please do take the time to respond to the request the questions in the survey so that Bspghan can support members in capturing beneficial clinical changes

Update to RCPCH advice – Shielding children
BSPGHAN continues to work with colleagues in the RCPCH to produce guidance on  which children remain more at risk of COVID-19 related disease.  It hasn’t been straightforward to produce the update with the uncertainty of what the releasing of lockdown/ school return will mean at this stage of the pandemic. Publication of the document is expected this week. The delay will allow engagement with colleagues in primary care, and more widely across the UK through the CMOs, thereby maximising the benefits of the update into a wider policy around shielding.

Resetting, restoring and recovering services
The ability of PGHAN services to deliver care during the pandemic has also been tested. Now we are moving forward re-starting services. The need for ‘COVID- safe’ practice with social distancing, will be a reality for the medium to long term and challenge our ability to manage the backlog of clinics and endoscopy cases. 

A robust system of documenting patients waiting, and triaging is important.

The RCPCH has set out principles for recovery here:-

  • Planning children’s health services should be reset and underpinned by data and evidence so that innovation and new models of care that meet the needs of children and young people are maintained.
  • Delivery of children’s health services should be restored so that all children and young people receive high-quality, safe and effective care in every setting, ensuring timely diagnosis with a particular focus on supporting community services. There should be no diminution in facilities and adherence to current standards must be maintained.
  • The paediatric workforce should be recovered, bringing paediatricians back to children’s services and their training pathway, including sharing new ways of working with a focus on wellbeing.

Capturing beneficial clinical changes in the NHS  – please check the NHS E survey questions in the link and please respond to enable Bspghan to share innovative ways of working with members.

In response to the challenges of delivering care during the pandemic, new and innovative ways of working have been rapidly developed across the NHS.
 As we move into the next phase of NHS recovery, NHSEI wants to ensure beneficial changes to care are embedded in our services so that patients benefit over the next 12 months and beyond.
BSPGHAN will send in a response, to be populated by your returns.
I am keen to hear from everyone (not just from those in England), what beneficial clinical changes/ innovations have occurred within our  speciality to share with members. 
Please think of examples of what you’ve seen working well that should be captured and sustained, and what is needed the sustain the change.
It would be handy to describe the impact of these innovations in terms of patient’s outcomes , safety, productivity and how the benefits are measured.

Please  do take the time to :-

  1. a) email me at with your examples and
  2. b) open the short survey questions in this link – members in England can of course respond and  share your thoughts too.

Impact of pandemic on Training

Training have  been disrupted with a loss of the usual learning opportunities, particularly where  endoscopy procedures and clinics have not taken place. 

As clinical services begin to be restored, the urgency to deliver on the backlog of elective care, and the need to limit face-to-face clinics will continue to compromise training opportunities.

BSPGHAN Trainees have found ways to interact and learn with weekly Zoom teaching to make up for lack of opportunities to meet the curricular requirements in the expected way.

BSPGHAN will support these sessions  and endorse these as we hear that for around 50% of trainees, formal weekly teaching has not been restored.

Trainees have been advised by CSACthat changes have been made to ARCP outcomes; see  to enable as many doctors in training as possible to progress. PGHAN supervisors are asked to focus on delivering high quality supervision and teaching with clear plans to address the shortfall in experience that has resulted from the loss of training opportunities during the pandemic.

Interesting read

Epidemiology, Clinical Features, and Disease Severity in Patients with Coronavirus Disease 2019 (COVID-19) in a Children’s Hospital in New York City, New York

Key findings from a case series of 50 children and adolescents  21 years and younger hospitalized with COVID-19 infection.

  • Respiratory symptoms, while common, were not always present.
  • Children commonly had comorbidities (immunosuppression including solid organ transplant * neurological disease, asthma, genetic and cardiac disease etc)
  • Infants and immunocompromised patients were not at increased risk of severe disease.
  • Obesity was significantly associated with disease severity.
  • Elevated inflammatory markers were seen in those with severe disease.

*including hepatitis in one patient who received a liver transplant for whom the donor was found to be SARS-CoV-2–positive posttransplant 
I hope that these updates are of interest and that you and your family and friends continue in good health.
As always, I welcome your feedback via email

Sue Protheroe
BSPGHAN President
7th June 2020

BSPGHAN Updated Shielding Guidance and Advice on Returning to School for Children with Gastrointestinal, Liver and Nutritional problems

BSPGHAN Updated Shielding Guidance and Advice on Returning to School for Children with Gastrointestinal, Liver and Nutritional problems

Dear members,  

Please find:

1. BSPGHAN Updated shielding guidance and advice on returning to school for children with gastrointestinal, liver and nutritional problems and

2. BSPGHAN IBD Working Group – Coronavirus (SARS-CoV-2) and COVID-19 in children with IBD- Position Statement: Guidance for Returning to School 

Best wishes Sue Protheroe 

BSPGHAN President 

28th May 2020 

Contact Us  l  Privacy Policy  l  Administration   

© 2020 British Society of Paediatric Gastroenterology, Hepatology and Nutrition  l Charity Number 299294 l VAT registration number 323665308
Website design and development by KYL.